Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:EMD_Serono
gptkb:Merck_Serono gptkb:Serono |
| gptkbp:appointed_by |
injection
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availability |
prescription only
|
| gptkbp:brand |
gptkb:Gonal-f
|
| gptkbp:class |
gonadotropins
|
| gptkbp:clinical_trial |
gptkb:physicist
Phase III Gonal-f vs. other gonadotropins |
| gptkbp:contraindication |
ovarian cysts
tumors of the pituitary gland hypersensitivity to follitropin alfa uncontrolled adrenal insufficiency |
| gptkbp:dosage_form |
solution for injection
|
| gptkbp:duration |
varies by protocol
|
| gptkbp:education |
storage instructions
monitoring requirements injection technique side effects awareness treatment goals |
| gptkbp:frequency |
daily
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gonal-f
|
| gptkbp:indication |
ovarian stimulation
|
| gptkbp:ingredients |
follitropin alfa
|
| gptkbp:interacts_with |
other fertility medications
|
| gptkbp:is_compatible_with |
certain medications
|
| gptkbp:is_monitored_by |
estradiol levels
ovarian response |
| gptkbp:is_used_for |
fertility treatment
|
| gptkbp:manager |
subcutaneous
|
| gptkbp:manufacturer |
gptkb:Merck_Serono
|
| gptkbp:marketed_as |
multiple countries
|
| gptkbp:packaging |
pre-filled syringe
|
| gptkbp:population |
women undergoing IVF
women with anovulation |
| gptkbp:provides_information_on |
ESHRE guidelines
ASRM guidelines |
| gptkbp:research |
cost-effectiveness analysis
long-term safety dosing regimens efficacy in PCOS ovarian response variability |
| gptkbp:safety_features |
generally well tolerated
|
| gptkbp:side_effect |
headache
nausea abdominal pain thromboembolic events mood swings multiple pregnancies ovarian hyperstimulation syndrome local injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:treatment |
gonadotropin
|